OverviewChartNewsTraderScreen

ZimVie Inc/  US98888T1079  /

IEX
2024-04-30  8:24:03 PM Chg. -0.49 Volume Bid- Ask- High Low
15.17USD -3.10% 2,976
Turnover: 45,806.57		 -Bid Size: - -Ask Size: - 15.53 15.17
GlobeNewswire 04-24 ZimVie to Report First Quarter Financial Results on May 8, 2024
GlobeNewswire 04-01 ZimVie Announces Closing of Sale of Spine Business
GlobeNewswire 03-27 ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 02-28 ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-21 ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
GlobeNewswire 02-07 ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
GlobeNewswire 2023-12-18 ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
GlobeNewswire 2023-12-12 ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma...
GlobeNewswire 2023-11-01 ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
GlobeNewswire 2023-10-31 ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
GlobeNewswire 2023-10-24 ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
GlobeNewswire 2023-10-17 ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
GlobeNewswire 2023-10-11 ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
GlobeNewswire 2023-10-10 ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
GlobeNewswire 2023-09-26 ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
GlobeNewswire 2023-08-17 ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
GlobeNewswire 2022-03-01 ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors